Gelteq Limited announced a three‑year sales agreement with Shenzhen Mana Health Management Co. Ltd., giving the Chinese distributor exclusive rights to promote, market and sell Gelteq’s proprietary nutritional gel formulation across China’s digital and offline retail channels.
The agreement is a significant revenue driver for Gelteq, whose trailing‑twelve‑month revenue was only $270,000 and which reported a net loss of AUD 6.65 million in the year ended June 30, 2025. The minimum annual order volumes under the deal are expected to generate roughly $1.3 million in revenue over the three‑year term, a 480 % increase over the company’s current annual sales and a predictable cash‑flow stream that can support ongoing R&D and market‑penetration initiatives.
China’s nutraceutical market is expanding rapidly, with the country’s segment projected to reach $109.89 billion by 2033 from $58.04 billion in 2024. Gelteq’s gel‑based delivery technology offers a unique proposition in a market that values functional nutrition and convenient consumption formats. By leveraging Mana’s established distribution network and digital presence, Gelteq can accelerate adoption of its platform in a high‑growth region and position itself for future product launches that incorporate its technology.
CEO Nathan Givoni said the partnership “represents a significant milestone in expanding nutritional products featuring Gelteq’s technology in China. By securing multi‑year minimum commitments from distributors such as Mana, we seek to generate predictable revenue and advance the adoption of our platform in one of the most strategically important markets for nutritional products globally.”
The deal also opens the door for future product launches that incorporate Gelteq’s technology, potentially expanding the company’s revenue base beyond its current nutritional portfolio and strengthening its competitive position in the Asian market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.